267 related articles for article (PubMed ID: 23959774)
1. Malignant mesothelioma: development to therapy.
Thompson JK; Westbom CM; Shukla A
J Cell Biochem; 2014 Jan; 115(1):1-7. PubMed ID: 23959774
[TBL] [Abstract][Full Text] [Related]
2. Cyclooxygenase-2, epidermal growth factor receptor, and aromatase signaling in inflammation and mesothelioma.
Nuvoli B; Galati R
Mol Cancer Ther; 2013 Jun; 12(6):844-52. PubMed ID: 23729401
[TBL] [Abstract][Full Text] [Related]
3. Asbestos-related lung cancer and malignant mesothelioma of the pleura: selected current issues.
Markowitz S
Semin Respir Crit Care Med; 2015 Jun; 36(3):334-46. PubMed ID: 26024342
[TBL] [Abstract][Full Text] [Related]
4. Clinicopathologic characteristics of malignant mesotheliomas arising in patients with a history of radiation for Hodgkin and non-Hodgkin lymphoma.
Chirieac LR; Barletta JA; Yeap BY; Richards WG; Tilleman T; Bueno R; Baldini EH; Godleski J; Sugarbaker DJ
J Clin Oncol; 2013 Dec; 31(36):4544-9. PubMed ID: 24248693
[TBL] [Abstract][Full Text] [Related]
5. [Malignant pleural mesothelioma].
Sritharan SS; Frandsen JL; Omland Ø; Bruun JM
Ugeskr Laeger; 2018 Apr; 180(15):. PubMed ID: 29690982
[TBL] [Abstract][Full Text] [Related]
6. Association of Asbestos Exposure With Malignant Mesothelioma Incidence in Eastern China.
Mao W; Zhang X; Guo Z; Gao Z; Pass HI; Yang H; Carbone M
JAMA Oncol; 2017 Apr; 3(4):562-564. PubMed ID: 27918607
[No Abstract] [Full Text] [Related]
7. Long-Fiber Carbon Nanotubes Replicate Asbestos-Induced Mesothelioma with Disruption of the Tumor Suppressor Gene Cdkn2a (Ink4a/Arf).
Chernova T; Murphy FA; Galavotti S; Sun XM; Powley IR; Grosso S; Schinwald A; Zacarias-Cabeza J; Dudek KM; Dinsdale D; Le Quesne J; Bennett J; Nakas A; Greaves P; Poland CA; Donaldson K; Bushell M; Willis AE; MacFarlane M
Curr Biol; 2017 Nov; 27(21):3302-3314.e6. PubMed ID: 29112861
[TBL] [Abstract][Full Text] [Related]
8. The assessment of the malignant mesothelioma cases and environmental asbestos exposure in Sivas province, Turkey.
Berk S; Yalcin H; Dogan OT; Epozturk K; Akkurt I; Seyfikli Z
Environ Geochem Health; 2014 Feb; 36(1):55-64. PubMed ID: 23553125
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic biomarker of asbestos-related mesothelioma: example of translational research.
Okio H; Kazu S; Masahiro M
Cancer Sci; 2007 Aug; 98(8):1147-51. PubMed ID: 17532755
[TBL] [Abstract][Full Text] [Related]
10. Peritoneal mesothelioma: the site of origin matters.
Kindler HL
Am Soc Clin Oncol Educ Book; 2013; ():182-8. PubMed ID: 23714495
[TBL] [Abstract][Full Text] [Related]
11. Natural history and epidemiology of malignant mesothelioma.
Antman KH
Chest; 1993 Apr; 103(4 Suppl):373S-376S. PubMed ID: 8462328
[TBL] [Abstract][Full Text] [Related]
12. Disease Latency according to Asbestos Exposure Characteristics among Malignant Mesothelioma and Asbestos-Related Lung Cancer Cases in South Korea.
Huh DA; Chae WR; Choi YH; Kang MS; Lee YJ; Moon KW
Int J Environ Res Public Health; 2022 Nov; 19(23):. PubMed ID: 36498008
[TBL] [Abstract][Full Text] [Related]
13. Advances in systemic therapy for malignant mesothelioma: future perspectives.
Sobhani N; Corona SP; Bonazza D; Ianza A; Pivetta T; Roviello G; Cortale M; Guglielmi A; Zanconati F; Generali D
Future Oncol; 2017 Oct; 13(23):2083-2101. PubMed ID: 28984470
[TBL] [Abstract][Full Text] [Related]
14. Malignant mesothelioma diagnosed at a younger age is associated with heavier asbestos exposure.
Dragani TA; Colombo F; Pavlisko EN; Roggli VL
Carcinogenesis; 2018 Sep; 39(9):1151-1156. PubMed ID: 29982378
[TBL] [Abstract][Full Text] [Related]
15. Malignant Mesothelioma of Spermatic Cord in an Elderly Man With a History of Asbestos Exposure.
D'Antonio A; Mastella F; Colucci A; Silvestre G
Urology; 2016 Jan; 87():e1-3. PubMed ID: 26433083
[TBL] [Abstract][Full Text] [Related]
16. Latest developments in our understanding of the pathogenesis of mesothelioma and the design of targeted therapies.
Bononi A; Napolitano A; Pass HI; Yang H; Carbone M
Expert Rev Respir Med; 2015 Oct; 9(5):633-54. PubMed ID: 26308799
[TBL] [Abstract][Full Text] [Related]
17. Peripheral Blood DNA Methylation as Potential Biomarker of Malignant Pleural Mesothelioma in Asbestos-Exposed Subjects.
Guarrera S; Viberti C; Cugliari G; Allione A; Casalone E; Betti M; Ferrante D; Aspesi A; Casadio C; Grosso F; Libener R; Piccolini E; Mirabelli D; Dianzani I; Magnani C; Matullo G
J Thorac Oncol; 2019 Mar; 14(3):527-539. PubMed ID: 30408567
[TBL] [Abstract][Full Text] [Related]
18. [Mesothelioma: a still current occupational cancer].
Corhay JL; Duysinx B; Louis R
Rev Med Liege; 2008 Mar; 63(3):128-35. PubMed ID: 18561768
[TBL] [Abstract][Full Text] [Related]
19. Consensus Report of the 2015 Weinman International Conference on Mesothelioma.
Carbone M; Kanodia S; Chao A; Miller A; Wali A; Weissman D; Adjei A; Baumann F; Boffetta P; Buck B; de Perrot M; Dogan AU; Gavett S; Gualtieri A; Hassan R; Hesdorffer M; Hirsch FR; Larson D; Mao W; Masten S; Pass HI; Peto J; Pira E; Steele I; Tsao A; Woodard GA; Yang H; Malik S
J Thorac Oncol; 2016 Aug; 11(8):1246-1262. PubMed ID: 27453164
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic value of microRNAs in asbestos exposure and malignant mesothelioma: systematic review and qualitative meta-analysis.
Micolucci L; Akhtar MM; Olivieri F; Rippo MR; Procopio AD
Oncotarget; 2016 Sep; 7(36):58606-58637. PubMed ID: 27259231
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
